U.S. Markets closed
S&P Futures
3,338.00-6.25(-0.19%)Dow Futures
27,222.00-63.00(-0.23%)Nasdaq Futures
11,250.75-10.50(-0.09%)
Haemonetics Corporation (HAE)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
75.65-0.46 (-0.60%)
At close: 4:00PM EDT
75.65 0.00 (0.00%)
After hours: 4:15PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 76.11 |
| Open | 76.00 |
| Bid | 75.60 x 800 |
| Ask | 75.63 x 1100 |
| Day's Range | 74.48 - 76.23 |
| 52 Week Range | 63.41 - 140.36 |
| Volume | 669,201 |
| Avg. Volume | 683,196 |
| Market Cap | 3.835B |
| Beta (5Y Monthly) | 0.66 |
| PE Ratio (TTM) | 40.83 |
| EPS (TTM) | 1.85 |
| Earnings Date | Oct 30, 2020 - Nov 03, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 113.67 |
- Zacks
Haemonetics (HAE) Q1 Earnings Beat Estimates, Margins Down
Haemonetics' (HAE) first-quarter fiscal 2021 results reflect impressive performance by Blood Center segment despite dismal overall performance during the coronavirus-led crisis.
- Simply Wall St.
Haemonetics Corporation (NYSE:HAE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
It is hard to get excited after looking at Haemonetics' (NYSE:HAE) recent performance, when its stock has declined 26...
- Zacks
Haemonetics (HAE) Surpasses Q1 Earnings and Revenue Estimates
Haemonetics (HAE) delivered earnings and revenue surprises of 12.20% and 1.35%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
© 2020 Verizon Media. All rights reserved.
